RM
While investigating the factors associated with mortality in neonates with necrotizing enterocolitis (NEC), we noted with interest the case report by Srinivasan et al. 1 describing episodic allergic enteritis in a preterm infant associated with corresponding elevated eosinophil counts. To our knowledge, eosinophils in stool remain the hallmark of allergic enterocolitis, but we were intrigued with the idea that systemic eosinophil elevation might be a reliable finding for this disease entity in preterm infants. Because we were working with a large dataset (Pediatrix Clinical Data Warehouse) consisting of predominantly preterm infants, we wondered if eosinophilia might reliably correlate with allergic enterocolitis and thus, if used as a surrogate identifier, whether or not it might identify a subset of NEC consistent with that diagnosis. To that end, we separated our population of NEC patients into all those with available eosinophil counts at time of NEC diagnosis <10% or X10%. Our results can be seen in the following Table 1 .
We think there are several trends of interest. First, there is a lower death rate (P ¼ 0.04) with a higher eosinophil count. This supports a supposition made by the Srinivasan group that allergic enterocolitis is a more benign entity than NEC in general. Second, infants presenting with a higher eosinophil count show trends toward lower gestation and birth weights but later time of onset. These findings are consistent with preterm infants acquiring allergic enterocolitis over time postnatally (another postulate in evidence by their case study). Finally, in our data set, the infants we arbitrarily defined as having eosinophilia were likely substantially higher in their eosinophilia counts when compared with another report by Dr Juul et al.
2 that examined the incidence and extent of eosinophilia in a single-center neonatal cohort. (Thus, we probably underestimated the true incidence of NEC with eosinophilia in our dataset.) None-the-less, our findings suggest allergic enterocolitis might be the dominant cause of eosinophilia in preterm infants. Indeed, Dr Juul's group found that the infants with the highest eosinophil counts were extremely preterm infants with NEC or allergic enterocolitis. Based on our combined findings, we pose the following questions: First, has the field of neonatology been habitually underestimating the incidence of allergic enterocolitis? Second, can the eosinophil count be used to improve our diagnosis of this disease entity? Third, could the potential unrecognized prevalence of allergic enterocolitis explain the reduction in NEC recently demonstrated with exclusive feeding of human milk products in preterm infants? 3 We welcome feedback from the authors of the papers that prompted this letter as well as the readership at large. We recognize that a major limitation of our dataset is a lack of reliable feeding history. Our hope is that the publication of our limited dataset will stimulate others to investigate these questions more thoroughly.
